Hotchkis & Wiley Capital Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,647,243
| Closed | -$3.95M | – | 495 |
|
|
2023
Q4 | $3.95M | Sell |
1,647,243
-781,247
| -32% | -$1.87M | 0.01% | 404 |
|
|
2023
Q3 | $8.26M | Buy |
2,428,490
+1,294,070
| +114% | +$4.4M | 0.03% | 244 |
|
|
2023
Q2 | $8.34M | Buy |
1,134,420
+190,760
| +20% | +$1.4M | 0.03% | 234 |
|
|
2023
Q1 | $9.78M | Buy |
943,660
+106,300
| +13% | +$1.1M | 0.04% | 177 |
|
|
2022
Q4 | $9.89M | Buy |
837,360
+484,860
| +138% | +$5.73M | 0.04% | 158 |
|
|
2022
Q3 | $7.4M | Buy |
352,500
+80,440
| +30% | +$1.69M | 0.03% | 205 |
|
|
2022
Q2 | $8.45M | Buy |
272,060
+28,800
| +12% | +$894K | 0.03% | 200 |
|
|
2022
Q1 | $9.99M | Buy |
243,260
+13,030
| +6% | +$535K | 0.03% | 181 |
|
|
2021
Q4 | $10M | Buy |
230,230
+79,000
| +52% | +$3.43M | 0.03% | 151 |
|
|
2021
Q3 | $7.57M | Buy |
+151,230
| New | +$7.57M | 0.02% | 222 |
|
|
2019
Q1 | – | Sell |
-35,794
| Closed | -$2.12M | – | 489 |
|
|
2018
Q4 | $2.12M | Sell |
35,794
-11,754
| -25% | -$697K | 0.01% | 313 |
|
|
2018
Q3 | $3.13M | Buy |
47,548
+12,356
| +35% | +$813K | 0.01% | 307 |
|
|
2018
Q2 | $1.78M | Buy |
35,192
+15,685
| +80% | +$792K | 0.01% | 343 |
|
|
2018
Q1 | $1.03M | Hold |
19,507
| – | – | ﹤0.01% | 317 |
|
|
2017
Q4 | $906K | Buy |
+19,507
| New | +$906K | ﹤0.01% | 324 |
|